{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:10:04Z","timestamp":1771920604145,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.009","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T23:19:42Z","timestamp":1309216782000},"page":"868-872","source":"Crossref","is-referenced-by-count":7,"title":["Ischemic Stroke in Patients Receiving Aspirin"],"prefix":"10.1016","volume":"21","author":[{"given":"Virginia A.","family":"Pujol Lereis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Ameriso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo P.","family":"Povedano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n F.","family":"Ameriso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib1","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1161\/CIRCULATIONAHA.107.187998","article-title":"Heart disease and stroke statistics\u20142008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.STR.13.3.290","article-title":"Survival and recurrence following stroke. The Framingham Study","volume":"13","author":"Sacco","year":"1982","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.STR.0000116183.50167.D9","article-title":"Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study","volume":"35","author":"Hardie","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists\u2019 Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archneur.62.8.1217","article-title":"Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke","volume":"62","author":"Maulaz","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"6 Suppl","key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib8","doi-asserted-by":"crossref","first-page":"630S","DOI":"10.1378\/chest.08-0720","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Albers","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib12","unstructured":"Merck. Merck Statement on Changes to Clinical Studies of Vorapaxar. 2011. Available from: http:\/\/www.merck.com\/newsroom\/news-release-archive\/research-and-development\/2011_0113.html. Accessed June 6, 2011."},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/187152907782793590","article-title":"Variability in individual responsiveness to aspirin: Clinical implications and treatment","volume":"7","author":"Coma-Canella","year":"2007","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.STR.25.2.275","article-title":"Failure of aspirin treatment after stroke","volume":"25","author":"Bornstein","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2165\/11536000-000000000-00000","article-title":"Antiplatelet drugs\u2014Do we need new options? With a reappraisal of direct thromboxane inhibitors","volume":"70","author":"Coccheri","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248409339309","article-title":"Platelet function testing and implications for clinical practice","volume":"14","author":"Collet","year":"2009","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-142-5-200503010-00012","article-title":"Narrative review: Aspirin resistance and its clinical implications","volume":"142","author":"Sanderson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1160\/TH07-05-0324","article-title":"The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis","volume":"98","author":"Blindt","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2004.03.069","article-title":"Prevalence of aspirin resistance measured by PFA-100","volume":"101","author":"Coma-Canella","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0038-1657677","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty","volume":"78","author":"Mueller","year":"1997","journal-title":"Thromb Haemost"},{"issue":"3 Suppl","key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib23","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/STROKEAHA.110.609404","article-title":"The perils of combination antithrombotic therapy and potential resolutions","volume":"42","author":"Fisher","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000147455","article-title":"Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke","volume":"26","author":"Karepov","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib30","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.326.7380.82","article-title":"Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia","volume":"326","author":"Friend","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib32","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.98.25.2822","article-title":"Increased formation of distinct F2 isoprostanes in hypercholesterolemia","volume":"98","author":"Reilly","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Davi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib34","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","article-title":"Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs","volume":"108","author":"Kurth","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2011.05.009_bib36","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/jcbfm.2008.9","article-title":"Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity","volume":"28","author":"Englyst","year":"2008","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305711001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305711001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T12:10:35Z","timestamp":1560341435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305711001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1052305711001169"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2011.05.009","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}